Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs

Biomaterials

Volumn 25, Issue 14, 2004, Pages 2843-2849

  Dong, Yuancai ^a   Feng, Si Shen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

AFM (atomic force microscopy); Biodegradable polymers; Chemotherapy; Taxanes; XPS (X ray photoelectron spectroscopy)

Indexed keywords

ATOMIC FORCE MICROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGHT SCATTERING; MORPHOLOGY; POLYETHYLENE GLYCOLS; PRECIPITATION (CHEMICAL); SURFACE CHEMISTRY; X RAY PHOTOELECTRON SPECTROSCOPY;

ENCAPSULATION EFFICIENCY (EE); STERIC STABILITY;

DRUG PRODUCTS;

MACROGOL; NANOPARTICLE; PACLITAXEL; POLYLACTIDE; POLYMER;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGHT SCATTERING; NANOTECHNOLOGY; PARTICLE SIZE; PRIORITY JOURNAL; STEREOCHEMISTRY; SUSPENSION; SYNTHESIS; VISCOSITY; X RAY PHOTOELECTRON SPECTROSCOPY; ZETA POTENTIAL;

EID: 1042264211     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2003.09.055     Document Type: Article

References (44)

1. Brigger I., Dubernet C., Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev. 54:2002;631-651.
2. Yuan F., Leuning M., Huang S.K., Berk D.A., Papahadjopoulos D., Jain R.K. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in human tumor xenograft. Cancer Res. 54:1994;3352-3356.
3. Desai M.P., Labhasetwar V., Walter E., Levy R.J., Amidon G.L. The mechanism of uptake of biodegradable microparticles in CaCO-2 cells is size dependant. Pharm Res. 14:1997;1568-1573.
4. 14C-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats. Biomaterials. 13:1992;1093-1102.
5. 14C poly (DL-lactide-co-glycolide) nanoparticles after intravenous and oral administration to mice. Int J Pharm. 106:1994;201-211.
6. Panagi Z., Beletsi A., Evangelatos G., Livaniou E., Ithakissios D.S., Avgoustakis K. Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles. Int J Pharm. 221:2001;143-152.
7. Moghimi S.M., Hunter A.C., Murray J.C. Long-circulating and target-specific nanoparticles. theory to practice Pharmacol Rev. 53:2001;283-318.
8. Storm G., Belliot S.O., Daemen T., Lasic D.D. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Deliv Rev. 17:1995;31-48.
9. Stolnik S., Illum L., Davis S.S. Long circulating microparticulate drug carriers. Adv Drug Deliv Rev. 16:1995;195-214.
10. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 263:1994;1600-1603.
11. Gref R., Domb A., Quellec P., Blunk T., Müller R.H., Verbavatz J.M., Langer R. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev. 16:1995;215-233.
12. Kwon G.S., Kataoka K. Block copolymer micelles as long-circulating drug vehicles. Adv Drug Deliv Rev. 16:1995;295-309.
13. Torchilin V.P., Papisov M.I. Hypothesis. why do polyethylene glycol-coated liposomes circulate so long? J Liposomes Res. 4:1994;725-739.
14. Blume G., Cevc G. Molecular mechanism of the lipid vesicle longevity in vivo. Biochim Biophys Acta. 1146:1993;157-168.
15. Das G.S., Rao G.H.R., Wilson R.F., Chandy T. Controlled release of taxol from poly (ethylene glycol)-coated poly (lactic acid) microspheres. J Biomed Mater Res. 55:2001;96-103.
16. Hawley A.E., Illum L., Davis S.S. Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake. Pharm Res. 14:1997;657-661.
17. Redhead H.M., Davis S.S., Illum L. Drug delivery in poly (lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908. in vitro characterization and in vivo evaluation J Control Rel. 70:2001;353-363.
18. Peracchia M.T., Gref R., Minamitake Y., Domb A., Lotan N., Langer R. PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers. investigations of their drug encapsulation and release characteristics J Control Rel. 46:1997;223-231.
19. Matsumoto J., Nakada Y., Sakurai K., Nakamura T., Takahashi Y. Preparation of nanoparticles consisted of poly (L-lactide)-poly (ethylene glycol)-poly (L-lactide) and their evaluation in vitro. Int J Pharm. 185:1999;93-101.
20. Jaeghere F.D., Allémann E., Leroux J.C., Stevels W., Feijen J., Doelker E., Gurny R. Formulation and lyoprotection of poly (lactic acid-coethylene oxide) nanoparticles. influence on physical stability and in vitro cell uptake Pharm Res. 16:1999;859-866.
21. Wani M.C., Taylor H.L., Wall M.E., Coggon P., McPhail A.T. Plant tumor agents. VI. The isolation and structure of Taxol, a novel antieukemic and antitumor agent from taxus brevifolia. J Am Chem Soc. 93:1971;2325-2327.
22. Rowinsky E.K., Onetto N., Canetta R.M., Arbuck S.G. Taxol. the first of the taxane, an important new class of antitumour agents Semin Oncol. 19:1992;646-662.
23. Rowinsky E.K., Donehover R.C. Paclitaxel (taxol). N Engl J Med. 332:1995;1004-1014.
24. Lopes N.M., Adams E.G., Pitts T.W., Bhuyan B.K. Cell kill kinetics and cell cycle effects of Taxol on human and hamster ovarian cell lines. Cancer Chemother Pharmacol. 32:1993;235-242.
25. Tatou E., Mossiat C., Maupoil V., Gabrielle F., David M., Rochette L. Effects of cyclosporin and cremophor on working rat heart and incidence of myocardial lipid peroxidation. Pharmacology. 52:1996;1-7.
26. Dorr R.T. Pharmacology and toxicology of Cremophor EL diluent. Ann Pharmacother. 28:1994;S11-S14.
27. Fjallskog M.L., Frii L., Bergh J. Is cremophor, solvent for paclitaxel, cytotoxic? Lancet. 342:1993;876.
28. Meerum Terwogt J.M., Nuijen B., Ten Bokkel Huinink W.W., Beijnen J.H. Alternative formulations of paclitaxel. Cancer Treat Rev. 23:1997;87-95.
29. Singla A.K., Garg A., Aggarwal D. Paclitaxel and its formulations. Int J Pharm. 235:2002;179-192.
30. ®). PLGA nanoparticles containing vitamin E TPGS J Control Rel. 86(1):2003;33-48.
31. Mu L., Feng S.S. Vitamin E TPGS as emulsifiers in the solvent evaporation/extraction technique for fabrication of polymeric nanoparticles for controlled release of paclitaxol. J Control Rel. 80:2002;129-144.
32. Fonseca C., Simões S., Gaspar R. Paclitaxel-loaded PLGA nanoparticles. preparation, physicochemical characterization and in vitro anti-tumoral activity J Control Rel. 83(2):2002;273-286.
33. Feng S.S., Huang G.F. Effects of emulsifiers on the controlled release of paclitaxel from nanoparticles of biodegradable polymers. J Control Rel. 71:2001;53-69.
34. Suh H., Jeong B., Rathi R., Kim S.W. Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly (ethylene oxide)-poly (lactide/glycolide) nanospheres. J Biomed Mater Res. 42:1998;331-338.
35. Fessi H., Puisieux F., Devissaguet J.P., Ammoury N., Benita S. Nanocapsule formation by interfacial deposition following solvent displacement. Int J Pharm. 55:1989;R1-R4.
36. Moghimi S.M., Porter C.J.H., Muir I.S., Illum L., Davis S.S. Non phagocytic uptake of intravenously injected microspheres in rat spleen. influence of particles size and hydrophilic coating Biochem Biophys Res Commun. 177:1991;861-866.
37. Konan Y.N., Gurney R., Allémann E. Preparation and characterization of sterile and freeze-dried sub-200. nm nanoparticles Int J Pharm. 233:2002;239-252.
38. Roy Boehm A.L.L., Zerrouk R., Fessi H. Poly epsilon-caprolactone nanoparticles containing a poorly soluble pesticides. formulation and stability study J Microencaps. 17:2000;195-205.
39. Molpeceres J., Guzman M., Aberturas M.R., Chacon M., Berges L. Application of central composite design to the preparation of polycaprolactone nanoparticles by solvent displacement. J Pharm Sci. 85:1996;206-213.
40. Chorny M., Fishbein I., Danenberg H.D., Golomb G. Lipophilic drug loaded nanospheres by nanoprecipitation. effect of formulation variables on size, drug recovery and release kinetics J Control Rel. 83:2002;389-400.
41. Paul M., Laatiris A., Fessi H., Dufeu B., Durand B., Deniau M., Astier A. Pentamidine-loaded poly (D,L-lactide) nanoparticles. adsorption and drug release Drug Dev Res. 43:1998;98-104.
42. Govender T., Stolnik S., Garnett M.C., Illum L., Davis S.S. PLGA nanoparticles prepared by nanoprecipitation. drug loading and release studies of a water soluble drug J Control Rel. 99:1999;171-185.
43. Mosqueira V.C.F., Legrana P., Pinto-Alphandary H., Puisieux F., Barratt B. Poly (D,L-lactide) nanocapsule prepared by a solvent displacement process. influence of the composition on physicochemical and structural properties J Pharm Sci. 89:2000;614-626.
44. Plard J.P., Bazile D. Comparison of the safety profile PLA50 and Me.PEG-PLA50 nanoparticles after single dose intravenous administration. Colloids Surf. B: Biointerfaces. 16:1999;73-83.